ERBB2 and cancer: Currently, immunohistochemical assays that detect abundance of proteins are used to identify expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and determine the rate of proliferation of the cancer cells (Ki67).